Last quarter (Q2 2023), Awakn Life Sciences's total revenue was C$24.62K, a decrease of -92.76% from the same quarter last year. In Q2, Awakn Life Sciences's net income was C$-1.75M. See Awakn Life Sciences’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Jan 23	Jan 22
Total Revenue	C$ 1.44M	C$ 1.50M	C$ 236.04K
Cost of Revenue	-	-	-
Gross Profit	C$ 1.44M	C$ 1.50M	C$ 236.04K
Operating Expense	C$ 9.09M	C$ 10.69M	C$ 11.19M
Operating Income	C$ -7.65M	C$ -9.19M	C$ -10.96M
Net Non Operating Interest Income Expense	C$ -191.69K	C$ -266.52K	C$ -205.43K
Other Income Expense	C$ -549.99K	C$ -615.49K	C$ 4.89M
Pretax Income	C$ -7.29M	C$ -9.65M	C$ -16.00M
Tax Provision	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	-
Net Income Common Stockholders	C$ -7.47M	C$ -9.14M	C$ -15.47M
Basic EPS	C$ -0.28	C$ -0.36	C$ -0.73
Diluted EPS	C$ -0.28	C$ -0.36	C$ -0.73
Basic Average Shares	C$ 107.18M	C$ 25.20M	C$ 21.96M
Diluted Average Shares	C$ 107.18M	C$ 25.20M	C$ 21.96M
Dividend Per Share	-	-	-
Total Operating Income As Reported	-	-	-
Reported Normalized Basic E P S	-	-	-
Reported Normalized Diluted E P S	-	-	-
Rent Expense Supplemental	-	-	-
Total Expenses	C$ 9.09M	C$ 10.69M	-
Net Income From Continuing And Discontinued Operation	C$ -7.47M	C$ -9.14M	C$ -15.47M
Normalized Income	C$ -4.79M	C$ -6.25M	C$ -11.76M
Interest Expense	-	-	-
EBIT	C$ -7.09M	C$ -9.39M	C$ -15.79M
EBITDA	C$ -6.77M	C$ -8.78M	C$ -15.61M

Currency in CAD

Awakn Life Sciences Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing